| negative regulation of insulin receptor signaling pathway |
| negative regulation of cellular response to insulin stimulus |
| SH3/SH2 adaptor activity |
| receptor tyrosine kinase binding |
| regulation of insulin receptor signaling pathway |
| regulation of cellular response to insulin stimulus |
| insulin receptor signaling pathway |
| cellular response to insulin stimulus |
| endosome membrane |
| response to insulin |
| cellular response to peptide hormone stimulus |
| cellular response to peptide |
| leukocyte migration |
| response to peptide hormone |
| response to peptide |
| transmembrane receptor protein tyrosine kinase signaling pathway |
| cellular response to organonitrogen compound |
| cellular response to hormone stimulus |
| cellular response to nitrogen compound |
| intracellular membrane-bounded organelle |
| enzyme linked receptor protein signaling pathway |
| protein homodimerization activity |
| response to hormone |
| cell migration |
| response to organonitrogen compound |
| cellular response to oxygen-containing compound |
| identical protein binding |
| cell motility |
| localization of cell |
| response to nitrogen compound |
| cellular response to endogenous stimulus |
| negative regulation of signal transduction |
| locomotion |
| negative regulation of cell communication |
| negative regulation of signaling |
| response to endogenous stimulus |
| movement of cell or subcellular component |
| response to oxygen-containing compound |
| negative regulation of response to stimulus |
| positive regulation of signal transduction |
| positive regulation of cell communication |
| positive regulation of signaling |